Af­ter spear­head­ing his­toric Covid ef­fort, Pfiz­er vac­cine R&D chief Kathrin Jansen to re­tire

The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on an experimental nasal spray to treat opioid overdoses.